These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 2954941)

  • 1. Effects of OKY 1581 on bronchoconstrictor responses to arachidonic acid and PGH2.
    Tilden SJ; Underwood DC; Cowen KH; Wegmann MJ; Graybar GB; Hyman AL; McNamara DB; Kadowitz PJ
    J Appl Physiol (1985); 1987 May; 62(5):2066-74. PubMed ID: 2954941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of thromboxane responses in the airway of the cat by SQ 29,548.
    Underwood DC; Kriseman T; McNamara DB; Hyman AL; Kadowitz PJ
    J Appl Physiol (1985); 1987 Jun; 62(6):2193-200. PubMed ID: 2440845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary vascular responses to thromboxane A2 as unmasked by OKY-1581. A novel inhibitor of thromboxane synthesis.
    Kadowitz PJ; Nandiwada PA; Spannhake EW; Rosenson RS; McNamara DB; Hyman AL
    Chest; 1983 May; 83(5 Suppl):72S-74S. PubMed ID: 6404609
    [No Abstract]   [Full Text] [Related]  

  • 4. Analysis of airway responses to A23187 in the cat.
    Kriseman T; Underwood DC; Hyman AL; Kadowitz PJ
    J Pharmacol Exp Ther; 1986 Nov; 239(2):395-9. PubMed ID: 3095538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelium-dependent and independent responses to prostaglandin H2 and arachidonic acid in isolated dog cerebral arteries.
    Toda N; Inoue S; Bian K; Okamura T
    J Pharmacol Exp Ther; 1988 Jan; 244(1):297-302. PubMed ID: 3121847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of thromboxane responses in the airway of the cat by SQ29,548 and OKY 1581.
    Kadowitz PJ; McNamara DB; Tilden SJ; Hyman AL; Underwood DC
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():535-8. PubMed ID: 2526533
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of OKY-046, a thromboxane A2 synthetase inhibitor, on arachidonate-induced platelet aggregation: possible role of "prostaglandin H2 steal" mechanism.
    Kuzuya T; Hoshida S; Yamagishi M; Ohmori M; Inoue M; Kamada T; Tada M
    Jpn Circ J; 1986 Nov; 50(11):1071-8. PubMed ID: 3102802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thromboxane synthase inhibition and perinatal pulmonary response to arachidonic acid.
    Tod ML; Cassin S
    J Appl Physiol (1985); 1985 Mar; 58(3):710-6. PubMed ID: 3920192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of arachidonic acid, PGF2 alpha, and a PGH2 analogue on airway diameters in dogs.
    Quan SF; Moon MA; Lemen RJ
    J Appl Physiol Respir Environ Exerc Physiol; 1982 Oct; 53(4):1005-14. PubMed ID: 7153109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thromboxane A2/prostaglandin H2 mobilizes calcium in human blood platelets.
    Brace LD; Venton DL; Le Breton GC
    Am J Physiol; 1985 Jul; 249(1 Pt 2):H1-7. PubMed ID: 3925795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandins and human platelet aggregation. Implications for the anti-aggregating activity of thromboxane-synthase inhibitors.
    Rajtar G; Cerletti C; Castagnoli MN; Bertelé V; de Gaetano G
    Biochem Pharmacol; 1985 Feb; 34(3):307-10. PubMed ID: 3918536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ONO-3122 (an enhancer of PGH2 production) and OKY-1581 (an inhibitor of TXA2 production) on the vasopressin-induced water flow in the toad bladder.
    Marumo F
    Pharmacology; 1985; 31(1):34-9. PubMed ID: 3927326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient concentrations and agonist potency of PGH2 in platelet activation by endogenous arachidonate.
    Hornberger W; Patscheke H
    Eicosanoids; 1989; 2(4):241-8. PubMed ID: 2517034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of SK&F 96148 on thromboxane-mediated responses in the airways of the cat.
    Dyson MC; Kadowitz PJ
    Eur J Pharmacol; 1991 May; 197(1):17-25. PubMed ID: 1909957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Action and metabolism of prostaglandins in the pulmonary circulation.
    Kadowitz PJ; Lippton HL; McNamara DB; Spannhake EW; Hyman AL
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():333-56. PubMed ID: 6216787
    [No Abstract]   [Full Text] [Related]  

  • 16. Thromboxane receptor antagonist properties of SQ 27,427 in the anesthetized guinea pig.
    Greenberg R; Steinbacher TE; Harris DN; Haslanger MF
    Eur J Pharmacol; 1984 Aug; 103(1-2):19-24. PubMed ID: 6090175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel arachidonic acid metabolites formed by prostaglandin H synthase.
    Hecker M; Ullrich V; Fischer C; Meese CO
    Eur J Biochem; 1987 Nov; 169(1):113-23. PubMed ID: 3119336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of endoperoxides in arachidonic acid-induced vasoconstriction in the isolated perfused kidney of the rat.
    Quilley J; McGiff JC; Nasjletti A
    Br J Pharmacol; 1989 Jan; 96(1):111-6. PubMed ID: 2522332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arachidonic acid-induced platelet aggregation is mediated by a thromboxane A2/prostaglandin H2 receptor interaction.
    Parise LV; Venton DL; Le Breton GC
    J Pharmacol Exp Ther; 1984 Jan; 228(1):240-4. PubMed ID: 6319669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of pulmonary thromboxane A2 synthase activity and airway responses by CGS 13080.
    McNamara DB; Harrington JK; Bellan JA; Graybar GB; Underwood DC; Kadowitz PJ
    Mol Cell Biochem; 1989 Jan; 85(1):29-41. PubMed ID: 2725478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.